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MTAP (5′-methylthioadenosine phosphorylase) catalyses the
reversible phosphorolytic cleavage of methylthioadenosine
leading to the production of methylthioribose-1-phosphate and
adenine. Deficient MTAP activity has been correlated with human
diseases including cirrhosis and hepatocellular carcinoma. In the
present study we have investigated the regulation of MTAP by
ROS (reactive oxygen species). The results of the present study
support the inactivation of MTAP in the liver of bacterial LPS
(lipopolysaccharide)-challenged mice as well as in HepG2 cells
after exposure to t-butyl hydroperoxide. Reversible inactivation of
purified MTAP by hydrogen peroxide results from a reduction
of Vmax and involves the specific oxidation of Cys136 and Cys223
thiols to sulfenic acid that may be further stabilized to sulfenyl
amide intermediates. Additionally, we found that Cys145 and
Cys211 were disulfide bonded upon hydrogen peroxide exposure.
However, this modification is not relevant to the mediation of the
loss of MTAP activity as assessed by site-directed mutagenesis.
Regulation of MTAP by ROS might participate in the redox regu-
lation of the methionine catabolic pathway in the liver. Reduced
MTA (5′-deoxy-5′-methylthioadenosine)-degrading activity may
compensate for the deficient production of the precursor S-adeno-
sylmethionine, allowing maintenance of intracellular MTA levels
that may be critical to ensure cellular adaptation to physio-
pathological conditions such as inflammation.
Key words: cysteine oxidation, inflammation, methylthioaden-
osine, methylthioadenosine phosphorylase, oxidative stress,
sulfenic acid.
INTRODUCTION
MTA (5′-deoxy-5′-methylthioadenosine) is a sulfur-containing
nucleoside that is present in all cell types including prokaryotes,
yeast, plants and higher eukaryotes. In mammalian tissues MTA is
generated from its precursor, decarboxylated SAM (S-adenosyl-
methionine), during the synthesis of polyamines spermine and
spermidine [1] or, alternatively, from the spontaneous splitting
of SAM under physiological conditions [2]. Although MTA has
been known for more than a century, its biological importance
was first proposed in 1952 [3]. The enzyme-catalysed conversion
of MTA into adenine and MTR1P (5-methylthioribose-1-phos-
phate) provides the first and rate-limiting step in purine and
methionine salvage pathways. MTR1P is recycled into methionine
and adenine is used to replenish the AMP and ATP pools [3].
Additionally to its central role in cellular metabolism, MTA also
participates in the regulation of a wide variety of cellular func-
tions. Intracellular fluctuations in MTA levels could participate
in the regulation of proliferative responses [4], as well as in
the modulation of inflammatory responses [5]. These effects
might be mediated by its inhibitory effect on polyamine biosyn-
thesis [6], by its capacity to interfere with key signalling
pathways through the inhibition of growth-factor-induced protein
tyrosine phosphorylation and cAMP phosphodiesterase [7], and
by the inhibition of protein methylation [3], a well-known
post-translational modification involved in the modulation of
cellular signalling and gene expression. Therefore it appears clear
that regulation of MTA levels is crucial to preserve cellular
homoeostasis. This concept is further reinforced by studies
suggesting the therapeutic potential of this natural compound in
different diseased conditions [8,9].
MTAP (5′-methylthioadenosine phosphorylase; 5′-deoxy-
5′-methylthioadenosine:orthophosphate methylthioribosyltrans-
ferase; EC 2.4.2.28) catalyses the reversible phosphorolytic
cleavage of MTA leading to the production of MTR1P and
adenine [10]. After the original description of this enzymatic
activity, MTAP has been purified and characterized from different
organisms and tissues [11,12]. Biochemical and structural
evidence indicate that mammalian MTAP is a trimer consisting
of three identical subunits of 32 kDa [13] that in humans contain
283 amino acid residues. MTAP is abundantly expressed in normal
cells and tissues [14] where it accounts for the production of most
of the free adenine generated in human cells [15]. In contrast,
lack of MTAP activity is frequently observed in tumour cells
[16]. The MTAP gene has been mapped to human chromosome
9p21 [14] in a region that is often deleted in tumour cells. In most
cases, it appears that the loss of MTAP activity or mRNA is the
result of homozygous deletions of the MTAP gene [17]. However
alternative mechanisms must also exist since MTAP impairment
was detected in lymphoma and melanoma-derived cell lines with
an intact MTAP gene [18,19]. The presence of a CpG island
proximal to the transcription start site of the MTAP promoter [18]
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has recently been reported, suggesting a transcriptional regulation
of the gene through a methylation/demethylation mechanism.
This notion was confirmed in HCC (hepatocellular carcinoma)
cell lines showing down-regulation of MTAP gene expression
that could not be attributed to genomic losses or mutations but to
promoter hypermethylation [20]. Additionally, it has been found
that the transcriptional activation of the human MTAP gene is
mediated by the binding of the CCAAT binding factor to a
distal CCAAT motif in the promoter [21]. Besides the regulation
at the transcriptional level, there is also evidence suggesting
modulation of MTAP activity. Phosphorylation of Ser183 and Thr188
residues have been recently reported, although the biological
transcendence of these modifications must be demonstrated
[22]. Oxidation also arises as a mechanism to modulate MTAP
activity as suggested by the requirement of the enzyme for
thiol-reducing agents and its specific and rapid inactivation by
thiol-blocking groups [23]. However, although the implication of
cysteine residues in the stabilization of the MTAP protein from
hyperthermophilic organisms through the formation of disulfide
bridges has been established [24], the role of specific thiols in the
modulation of MTAP activity is less evident.
In the present study we provide data supporting MTAP inactiv-
ation in the liver of mice after induction of an inflammatory
reaction by administration of LPS (lipopolysaccharide). Reduc-
tion of MTAP activity was also demonstrated in MTAP-expressing
HepG2 cells after exposure to t-butyl hydroperoxide. Reversible
inactivation of MTAP by ROS (reactive oxygen species) occurs
by specific oxidation of Cys136 and Cys223 to sulfenic acid as
illustrated by the loss of sensitivity of mutants in which these
residues were substituted by a serine residue. MTAP inactivation
by ROS arises then as a specific regulatory mechanism that might
be pivotal in cellular adaptation to physiological or pathological
conditions, such as inflammation, that involve oxidative stress.
MATERIALS AND METHODS
Animal experiments
Male C57Bl6 mice (mass of 19–21 g) were from Harlan.
Studies were approved by the University of Navarra Committee
on Animal Care and satisfied National Institutes of Health
guidelines for humane treatment of animals. Mice were injected
intraperitoneally with 15 mg/kg of endotoxin (Salmonella
typhimurium LPS; Sigma) dissolved in sterile, pyrogen-free
saline. Liver tissue was removed after 22 h, snap-frozen in liquid
nitrogen and stored at −80 ◦C until analysis.
SAM, SAH (S-adenosylhomocysteine) and MTA measurements
Liver samples (50 mg) were homogenized in 250 μl of 0.4 M per-
chloric acid. Homogenates were centrifuged at 10000 g at 4 ◦C for
15 min. SAM, SAH and MTA levels were measured in the super-
natant by HPLC as described previously [25]. Then, 100 μl ali-
quots were loaded on to a Bio-Sil® ODS-5S column equilibrated
in 0.01 M ammonium formate and 4 mM heptanesulfonic acid
(pH 4.0). MTA was eluted with a linear gradient (25–100%)
acetonitrile in the same buffer. Chromatograms were analysed
with the software 32 Karat 5.0 (Beckman Coulter).
Cell transfection
SK-Hep1 cells grown in 60-mm dishes until 70% confluence
were transfected with a pcDNA3.1 HisA plasmid harbouring the
complete human MTAP cDNA, or the empty pcDNA3.1 HisA
vector. Transfections were carried out using Tfx-1 (Promega)
according to the manufacturer instructions, and transfectants were
selected in complete medium containing 0.6 mg/ml of G418
sulfate (Geneticin; Invitrogen) as described previously [26]. After
two weeks, individual colonies were harvested, and clones were
transfected with the empty vector pcDNA3.1 HisA (SK-EV) or
the MTAP-expressing construct (SK-WT) were expanded.
MTAP activity in liver cell lines
HepG2 or SK-Hep1 cells (106) were plated on 60 mm dishes
and were incubated with DMEM (Dulbecco’s modified Eagle’s
medium) supplemented with 10% FBS (foetal bovine serum),
1% GPS (gentamicin-penicillin-streptomycin) and 0.6 mg/ml
G418. Then, after cell adhesion, cells were incubated overnight
with DMEM without methionine and supplemented with 10%
horse serum and 1% GPS, at 37 ◦C and 5% CO2. Then, after
40 min incubation with the indicated concentration of t-butyl
hydroperoxide at 37 ◦C, 16 μM MTA was added to the culture
medium. MTA consumption was determined by measuring the
extracellular MTA remaining after different incubation periods as
described above.
MTAP cloning and site-directed mutagenesis
Total human resting peripheral blood lymphocyte RNA was
isolated using the guanidinium thiocyanate method [27] and
was transcribed to cDNA using the Superscript pre-amplification
system (Invitrogen). The cDNA was amplified using Taq Long
Plus enzyme (Stratagene) and the sense (5′-CTCGAGATCTG-
CATGGCCTCTGGCACC-3′) and antisense (5′-ATGAATTCC-
TTAATGTCTTGGTAATAAAAC-3′) primers, derived from the
human MTAP subunit cDNA sequence. The PCR products
were purified using the QIAquick Gel Extraction kit (Qiagen)
and ligated into the expression vector pCDNA3.1, according
to the manufacturer’s instructions (Eukaryotic TA cloning
Kit Unidirectional; Invitrogen) or into the plasmid pRSETA
(Invitrogen), resulting in constructs that include a 5′-sequence
coding for six histidine residues and a protease-cleavage
site in-frame with the human MTAP-coding region. Cysteine
replacement by a serine residue was performed by site-directed
mutagenesis with the QuikChange® site-directed mutagenesis
kit (Stratagene) using the primers indicated in Supplementary
Table 1 (at http://www.BiochemJ.org/bj/411/bj4110457add.htm).
The cloned products and all mutants were confirmed by sequenc-
ing the complete MTAP cDNA. Stable transfectants of each
MTAP mutant were established in SK-Hep1 cells as described
above.
Expression and purification of recombinant MTAP
Recombinant WT (wild-type) and MTAP mutants were expressed
in Escherichia coli BL21(DE3) (Invitrogen) as described prev-
iously [28]. Cells were homogenized in 100 mM Tris/HCl (pH 8),
0.5 M NaCl with 1 mM benzamidine, 1 mM PMSF and 0.5 mg/
ml lysozyme. After 30 min incubation on ice, cell extracts
were obtained by sonication and the cytosolic fraction was
separated by ultracentrifugation at 75000 rev./min (rotor TLA
100.2; Beckman) at 4 ◦C for 1 h. Recombinant WT and MTAP
mutant proteins were purified from the bacterial cytosolic extracts
by affinity chromatography on a Ni2+-Sepharose column (GE
Healthcare) equilibrated in 50 mM Tris/HCl (pH 8), 0.5 M NaCl
and 40 mM imidazole. After washing with 10 column volumes
of equilibration buffer, elution was performed with a linear
gradient from 40 mM to 1 M imidazole in the same buffer. His-
tagged MTAP proteins eluted from the Ni2+ column at 250 mM
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imidazole. Protein purity was always more than 95% as estimated
by SDS/PAGE [29]. MTAP-containing fractions were pooled,
desalted with 5 ml HiPrep desalting columns (GE Healthcare)
and the protein concentration was determined using the Bio-Rad
protein assay kit based on the Bradford assay [30]. The purified
protein was then stored at −80 ◦C in the presence of 5 mM
DTT (dithiothreitol). Enterokinase processing was performed
using the Enterokinase Max assay (Invitrogen) according to the
manufacturer’s protocol.
MTAP activity assays
DTT was removed from the preparation with HiPrep desalting
columns equilibrated in 10 mM Tris/HCl (pH 7.4) and 10 mM
KCl immediately before use. Two independent procedures were
used to measure the activity of purified WT and MTAP mutant pro-
teins. The reaction mixture always contained 1 μM MTAP
protein or liver homogenates (400 μg of total protein) in 50 mM
phosphate buffer (pH 7.4) and the appropriate concentration of
MTA in a final volume of 400 μl. Pre-incubation with 5 mM DTT
or different H2O2 concentrations was performed as indicated. The
mixture was then incubated at 37 ◦C for the indicated period of
time and the reaction was stopped with perchloric acid to a final
concentration of 0.4 M. MTA measurements were performed by
HPLC as indicated previously. Alternatively, MTAP activity was
determined according to the procedure described by Singh et al.
[31]. Conditions were as described above. The reaction was started
by the addition of MTA and consumption was followed by the
reduction of the absorbance at 275 nm. H2O2 was added when
required to the enzyme and the mixture was incubated for 10 min
at 37 ◦C before adding MTA. Time-course assays were performed
in the presence of different concentrations of MTA and initial
velocity values were obtained in each case from the linear fitting
of the MTA variation in the first 3 min of the reaction. V i against
MTA concentration plots were fitted to the Michaelis–Menten
equation using Kaleidograph 3.5b5.
Quantification of free thiol groups and sulfenic derivatives
Purified MTAP was pre-incubated for 5 or 30 min with DTT
or the appropriate concentration of H2O2 that were subsequently
eliminated with a HiPrep desalting column equilibrated in 50 mM
phosphate buffer (pH 7.4). Free thiol groups were quantified
by incubation with DTNB [Ellman’s reagent; 5,5′-dithiobis-(2-
nitrobenzoic acid)] following the absorbance at 412 nm resulting
from the liberation of TNB [thiobis-(2-nitrobenzoic acid)] after
interaction with sulfhydryl groups. The DTNB reaction was
performed in a final volume of 400 μl containing 50 mM phos-
phate buffer (pH 7.4), 1 mM EDTA, 6 M guanidinium chloride,
25 μM protein and 20 mM DTNB. The amount of accessible
sulfhydryl groups was calculated by measuring the TNB released
using a molar extinction coefficient of 13600 M−1 · cm−1 [32,33].
Determination of sulfenic acid from cysteine SH oxidation was
performed using two different approaches. In the first method,
sulfenic acid was titrated with TNB according to the procedure
described by Poole et al. [34]. Protein samples prepared as
indicated above were incubated with 20 mM TNB at 25 ◦C for
30 min. The excess of TNB was then removed with HiPrep
desalting columns under the same conditions described above.
DTT was added (50 mM) to release the TNB associated to
SOH groups that was measured by absorbance at 412 nm.
Alternatively, NBD-Cl (4-nitrobenzo-2-oxa-1,3-diazole; 20 mM)
was used following the procedure described previously [35].
NBD-Cl was added to protein preparations and the mixture was
incubated at 25 ◦C for 30 min. After elimination of the NBD-Cl
excess with HiPrep desalting columns, SH-derived adducts and
sulfenic resulting derivatives were measured at 420 and 347 nm
respectively.
Size-exclusion chromatography
WT and MTAP mutants were chromatographed in a Superdex-
200 HR 10/30 column (GE Healthcare) equilibrated in 50 mM
Tris/HCl (pH 7.5). Isocratic elution with the same buffer (0.8 ml/
min) was monitored at 280 nm. The column was calibrated in
the same conditions using catalase (232 kDa), BSA (67 kDa),
trypsin (21 kDa) and ribonuclease A (13.7 kDa) as standards.
Alternatively MTAP was denatured by 2 h incubation with 6 M
guanidinium chloride after the indicated treatments. Unfolded
proteins were then analysed with the same column equilibrated in
100 mM Tris/HCl (pH 3.0) and 6 M guanidinium chloride.
MS analysis
Samples of MTAP protein (50–100 μg) were incubated with
500 μM H2O2 or 5 mM DTT and subsequently prepared for
MALDI–TOF-MS (matrix-assisted laser-desorption ionization–
time-of-flight MS) analysis (MALDI TOF GL-REF mass
spectrometer; Waters). After desalting to eliminate excess H2O2
or DTT, free cysteine residues were alkylated by a reaction
with 100 mM iodoacetamide for 30 min and the protein was
precipitated in chloroform/methanol (4:1). Protein pellets were
resuspended in 25 mM ammonium bicarbonate and incubated
with 2 μl of 50 μg/μl trypsin (Promega) at 37 ◦C for 12 h.
Alternatively, the protein was dissolved in 10 mM Tris/HCl
(pH 7.8), 10 mM calcium chloride and incubated with 2 μl
of 25 μg/μl chymotrypsin (Roche) at 25 ◦C for 12 h. Half of
the sample was then reduced with 10 mM DTT at 55 ◦C for
30 min. The digestion mix was desalted with reversed-phase
C18-ZipTip (Millipore). Then 1 μl of the resulting solutions
were mixed with an equal volume of CHCA (α-cyano-4-
hydroxy-trans-cynnamic acid) in 50% acetonitrile with 0.1%
TFA (trifluoroacetic acid) and spotted on to a MALDI target
plate. The system was calibrated daily with a tryptic digest
of ADH (alcohol dehydrogenase), and after analysis near-
point calibration was performed using corticotrophin [ACTH
(adrenocorticotrophic hormone)] as the lock-mass standard. Data
processing was performed with Masslynx release 4.0 (Waters) to
subtract background noise using polynomial order 10 with 10%
of the data points below this polynomial. Data were also smoothed
by one smooth operation (Savitzky Golay) with a window of
two channels. MS spectra were processed automatically with
MASCOT and then interpreted by manual inspection using
Masslynx 4.0 (Waters). The presence of disulfide bridges was
analysed using MS-Bridge 4.0.8 from the Protein prospector
webpage (http://prospector.ucsf.edu/).
Western blot analysis
Liver tissues and cultured cells were lysed and proteins
were extracted as previously described [7]. Equal amounts of
protein (20 μg) were resolved using SDS/PAGE (12.5% gels).
Proteins were electrophoretically transferred on to nitrocellulose
membranes for 45 min at 120 V. Membranes were probed with
a 1:5000 or 1:1000 dilution of anti-MTAP (the gift of Dr D.A.
Carson, University of California, San Diego, U.S.A.) or anti-(HO-
1) (haem oxygenase 1; Stressgene) antibodies respectively. Anti-
chicken and anti-rabbit IgG peroxidase-conjugated secondary
antibodies were used for MTAP and HO-1 assays. Blots were
developed by enhanced chemiluminiscence (PerkinElmer).
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Figure 1 MTAP inactivation in the liver of LPS challenged mice
(A) Hepatic levels of SAM, SAH and MTA in LPS-treated mice are represented as the percentage
of control values (100 %) measured in saline-injected animals (n = 6 per condition). The
100 % values were 38 +− 6.12, 12 +− 1.5 and 4.2 +− 1.1 pmol/mg of protein for SAM, SAH and
MTA respectively. (B) Levels of MTAP and HO-1 proteins were determined in control and
LPS-challenged mice by Western blotting (representative blots are shown).
RESULTS
Impaired MTA degradation in the liver of LPS-challenged mice
To evaluate MTA metabolism under oxidative stress, SAM, SAH
and MTA levels were measured in the liver of LPS-treated mice, a
well-known condition inducing a redox imbalance in hepatic cells.
As previously shown [36], the inflammatory reaction associated
with LPS administration induced a 50% reduction of hepatic
SAM and SAH. However, the MTA concentration was 2.5-fold
higher than that measured in control livers (Figure 1A). No change
in MTAP protein levels was observed upon LPS administration
as assessed by Western blot analysis (Figure 1B). In agreement
with previous studies [37], HO-1 expression was increased in
response to the oxidative stress associated with the inflammatory
reaction (Figure 1B). Since MTAP catalyses the only known MTA
catabolic reaction, the increase in hepatic MTA levels in LPS-
treated mice, even when the concentration of the precursor SAM
was diminished, suggests impairment in MTAP activity. In order
to further support this idea, MTAP activity was measured in liver
extracts from control and treated mice and a 65% inactivation
was observed upon LPS administration (1.52 +− 0.02 compared
with 0.66 +− 0.08 nmol MTA · min−1 · mg−1 of protein in controls
and challenged livers respectively).
ROS-mediated MTAP inactivation in hepatic cells
To investigate the effect of ROS on MTAP activity, HepG2 cells
were incubated with t-butyl hydroperoxide and the rate of exo-
genous MTA consumption was determined. As a negative control
the experiment was also performed with SK-Hep1 cells, which we
have previously shown to lack MTAP expression [19] (Figure 2B).
In all cases, the culture medium was deprived of methionine
to prevent endogenous MTA synthesis and was supplemented
with horse serum to avoid extracellular MTA degradation by the
MTAP present in the commonly used bovine serum [38]. MTA
was efficiently degraded by HepG2 MTAP activity within the
Figure 2 Impairment of MTAP activity in HepG2 cells upon an oxidative
challenge
HepG2 cells were incubated in the absence () or presence () of 1 μM t-butyl hydroperoxide,
and their capacity to metabolize MTA was measured. As a negative control the MTA-consuming
capacity of SK-Hep1 cells () lacking MTAP was measured under the same conditions (A). The
initial MTA concentration was 16 μM. The remaining MTA after the different incubation times
was measured in the culture medium by HPLC. The MTAP activity calculated for HepG2 cells
without t-butyl hydroperoxide was 971.95 pmol MTA consumed · mg−1 · min−1. (B) MTAP
levels were determined by Western blot analysis in HepG2 cells after 48 h in the absence
(lane 1) or presence (lane 2) of 1 μM t-butyl hydroperoxide and in SK-Hep1 cells (lane 3).
Values are means +− S.D. of three independent experiments.
first 30 h of incubation. As expected, the levels of MTA in the
culture medium remained unchanged in the presence of SK-Hep1
cells. Induction of oxidative stress with t-butyl hydroperoxide
significantly reduced the capacity of HepG2 cells to metabolize
the supplemented MTA (only 30% of the initial MTA was
degraded under these conditions), probably resulting from the
inactivation of the constitutive MTAP (Figure 2A). The steady-
state levels of MTAP protein remained unchanged upon t-butyl
hydroperoxide exposure (Figure 2B). These results suggest that
cellular MTAP is inactivated by ROS.
H2O2-induced MTAP inactivation
The activity of purified MTAP was measured before and after
digestion with enterokinase to determine the effect of the N-
terminal tag. Only preparations with more than 95% purity were
used for subsequent experiments. Digestion with enterokinase
removed the N-terminal tag and resulted in the expected 32 kDa
subunits as assessed by SDS/PAGE. Both tagged and digested
enzymes had similar MTA-degrading rates of 57.6 and 398 nmol ·
min−1 · mg−1 when the assay was performed with 15 and 200 μM
MTA respectively (results not shown). Since no apparent change
of activity was associated with the N-terminal tag, all the
experiments were carried out using the His-tagged recombinant
proteins. The putative effect of ROS on MTAP activity was studied
by pre-incubation of the enzyme with H2O2. Independently of
whether the protein was processed with enterokinase or not,
a 60% decrease of the enzymatic activity was measured after
oxidation and the inactivation was reversed when the activity assay
was performed in the presence of reducing agents (Supplementary
Figure at http://www.BiochemJ.org/bj/411/bj4110457add.htm).
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Table 1 Vmax and Km values for reduced and oxidized MTAP
V max (nmol MTA consumed · min−1 · mg−1) K m (μM)
MTAP 433 +− 29.37 32.77 +− 9.42
MTAP + 100 μM H2O2 271.9 +− 22.45 24.93 +− 9.78
MTAP + 500 μM H2O2 168.97 +− 8.34 37.18 +− 7.42
The hydrodynamic properties of the recombinant MTAP purified
from E. coli extracts were analysed by size-exclusion chromato-
graphy. The elution volume of recombinant MTAP was 13.28 ml,
which is compatible with a molecular mass of 108 kDa according
to the elution profile of standard proteins. This result indicates that
the purified MTAP is a trimer of tagged subunits. Since the elution
volume of the protein remained unchanged upon incubation with
H2O2 (13.22 ml), oxidation-associated changes of the trimeric
structure of MTAP were ruled out (results not shown). To get
an insight into the mechanism of H2O2-mediated inactivation of
MTAP, kinetic experiments were performed. Vmax was reduced
from 433 +− 29 to 169 +− 8 nmol MTA consumed · min−1 · mg−1 in
the absence or presence of 500 μM H2O2 respectively (Table 1
and Supplementary Figure 1). The estimated Km for MTA
(approx. 30 μM) remained unchanged upon oxidation (Table 1
and Supplementary Figure 1), suggesting that the loss of activity
might result from impairment of the catalytic mechanism more
than from impeded MTA binding to the active site of the enzyme.
Therefore these results suggest that H2O2 is a non-competitive
inhibitor with an estimated IC50 of approx. 300 μM.
Identification of target cysteine residues involved in the
impairment of MTAP activity by ROS
In order to elucidate the participation of cysteine residues on
MTAP inactivation by oxidation and to identify the targeted cys-
teine residue(s), nine mutant MTAP proteins in which a single
cysteine residue was replaced by a serine residue were obtained
and their susceptibility to inactivation by H2O2 was analysed.
Mutants were expressed and purified from E. coli extracts and the
purity of the corresponding proteins was always more than 95%
in all preparations used. Replacement of cysteine by serine had no
effect on the enzymatic activity of MTAP mutants. Similarly to the
WT enzyme, the activity measured at a saturating concentration
of MTA was close to 396 nmol MTA consumed · min−1 · mg−1 in
all cases (Figure 3A). Incubation with 500 μM H2O2 reduced
the activity of WT and mutant proteins to approx. 132 nmol
MTA consumed · min−1 · mg−1 with the exception of C136S and
C223S MTAP species that remained fully active after oxidation
(Figure 3A). These results suggest that the oxidation of both
Cys136 and Cys223 is required to mediate MTAP inactivation. The
loss of sensitivity to inactivation by ROS of C136S and C223S
mutants was also investigated in hepatic cells. In order to do this,
stably transfected SK-Hep1 cells expressing these two MTAP
mutants were challenged with 10 μM t-butyl hydroperoxide and
the consumption of extracellular MTA was measured after 30 h.
MTAP mutant protein levels (as determined by Western blot
analysis) and the capacity of MTA degradation by transfected
SK-Hep1 cells were similar to those observed in HepG2 cells
that express the endogenous enzyme (800–1000 pmol MTA
consumed · mg−1 · min−1). SK-Hep1 cells expressing either of the
two mutants were not sensitive to t-butyl hydroperoxide and their
MTA-metabolizing activity remained unchanged after exposure
to the oxidant (Figure 3B), further supporting the central role of
Cys136 and Cys223 in mediating MTAP inactivation by ROS. In
contrast, SK-Hep1 cells transfected with a vector expressing WT
Figure 3 Identification of cysteine residues mediating MTAP inactivation
by ROS
(A) The activity of WT and mutant MTAP proteins was measured in the absence (solid bars) or
presence (open bars) of 500 μM H2O2. The MTAP concentration was 1 μM in all cases and
the initial and final amount of MTA was measured by HPLC. (B) The MTA metabolizing rate
was measured in SK-Hep1 cells stably transfected with an empty vector (SK-EV) or expressing
human WT (SK-WT), C136S or C223S MTAP mutants in the absence (solid bars) or presence
(open bars) of 10 μM t-butyl hydroperoxide. MTA was added to the culture medium at an initial
concentration of 16 μM. The MTA content in the culture medium was measured by HPLC. The
Western blot shows MTAP levels in HepG2 (lane 1) and SK-Hep1 cells expressing WT MTAP
(lane 2), C136S (lane 3), C223S (lane 4) or transfected with an empty vector (lane 5). Values
are means +− S.D. of three independent experiments.
MTAP showed the expected decrease (approx. 60%) of MTA
consumption upon exposure to t-butyl hydroperoxide.
Identification of cysteine-SH oxidation derivatives
To characterize the thiol-oxidation derivatives leading to MTAP
inactivation we first measured the number of accessible cysteine
residues remaining upon incubation with H2O2. The protein
was oxidized and then denatured in 6 M guanidinium chloride
to ensure titration of all free cysteine residues with DTNB.
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Figure 4 MS detection of Cys145-S-S-Cys211 disulfide interaction
MALDI–TOF MS spectra of tryptic digests from (A) DTT treated, (B) H2O2 treated or (C) H2O2 and
then DTT treated WT MTAP were obtained. H2O2 was removed before chymotrypsinolysis to avoid
peptide cross-linking by disulfide interactions during digestion. The insert in (B) indicates the
sequence of the two MTAP peptides containing Cys145 and Cys211 whose interaction is consistent
with the H2O2-associated detection of a 1797.13 Da ion.
This procedure allowed detection of ten cysteine residues in
the reduced protein, which is compatible with the presence of
nine cysteine residues in the MTAP sequence and one additional
residue provided by the N-terminal tag. Incubation with H2O2 res-
tricted the access of the thiol-reacting reagent to four cysteine
residues independently of the time of exposure to the oxidant, sug-
gesting the oxidation of six cysteine residues as was further
supported by the recovery of reactivity of all ten cysteine resi-
dues with DTT. This evidence indicates oxidation of cysteine
residues additionally to those responsible for MTAP inactivation
by ROS. MS analyses were then performed on tryptic and chymo-
tryptic digests from reduced and H2O2-treated MTAP aiming
to identify cysteine residues involved in a putative disulfide
bonding. Ion assignment from MALDI–TOF spectra allowed
more than 60% coverage of the MTAP sequence in all cases.
Interestingly, a 1797.13 Da ion was specifically detected on
peptide fingerprints from H2O2-oxidized MTAP and the presence
of this peptide species was prevented when oxidation was reversed
with DTT (Figure 4). The differential ion might result from the
interaction between Cys145 and Cys211 leading to the association
Figure 5 Oxidation of Cys136 and Cys233 to sulfenic acid
Sulfenic acid derivatives were detected by incubation of reduced or oxidized native MTAP with
TNB or NBD-Cl (A). For TNB experiments, control (dashed line) or H2O2- (solid line), DTT-
(dotted line) and H2O2 and then DTT- (dashed and dotted line) treated MTAP were assayed.
For NBD-Cl, control (solid line) or H2O2 (dashed line) conditions were analysed. The number
of sulfenic derivatives per MTAP subunit was estimated by titration with TNB (B). Values are
means +− S.D. of three independent experiments.
of the corresponding chymotryptic peptides as suggested by
the experimental molecular mass which is 2 Da less than that
theoretically predicted from the sequence, in agreement with a di-
sulfide-bridged dipeptide. Since no additional cysteine derivatives
were identified, the oxidation state of Cys136 and Cys223,
responsible for MTAP inactivation, remained unclear. Oxidation
to sulfenic acid was then explored using TNB or, alternatively,
NBD-Cl. Control MTAP yielded negative results when incubated
with either sulfenic-specific reagents. However, after exposure to
H2O2, sulfenic acids were observed independently of the detection
method used and were not detectable if the oxidized and modified
enzyme were treated with DTT. TNB reagent allowed titration of
two sulfenic groups per MTAP subunit (Figure 5). Substitution
of Cys136 or Cys223 by serine resulted in MTAP variants that
contained only one sulfenic acid after oxidation (Figure 5).
These results indicate that H2O2-induced MTAP inactivation
results from oxidation of Cys136 and Cys223 to sulfenic acid. A
reduction of the 412 nm signal was observed if oxidation was
prolonged over 30 min, suggesting that the sulfenic groups might
evolve to more stable derivatives (Supplementary Figure 2 at
http://www.BiochemJ.org/bj/411/bj4110457add.htm).
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Figure 6 Schematic representation of MTA metabolism
Checkpoints modulated by redox imbalance are indicated. (1) Methionine adenosyltransferase, (2) methyl transferases, (3) S-adenosylmethionine decarboxylase, (4) ornithine decarboxylase,
(5) spermidine synthase, (6) spermine synthase and (7) 5′-methylthioadeosine phosphorylase.
DISCUSSION
The participation of MTA in essential metabolic and signalling
pathways suggests that the regulation of MTAP activity might
be important in facilitating cellular adaptation to physiological
or pathological conditions. The liver parenchyma is one of the
normal human tissue types where MTAP gene expression is
higher [39]. It has been demonstrated that methionine metabolism
must be precisely tuned to maintain normal liver function and
that impairment of this pathway correlates with hepatocyte de-
differentiation and proliferation leading to the progression of
liver diseases [4,40]. Consistent with the central role of MTA
in the cell, a conservative mechanism based on a co-ordinated
regulation of MAT (methionine adenosyltransferase), the enzyme
catalysing the synthesis of the precursor SAM, and MTAP might
prevent a deleterious MTA decrease in hepatocytes (Figure 6).
First, the oxidative stress resulting from mild and transient liver
damage inactivates MAT perhaps providing an adaptive response
that allows hepatocyte survival [41]. Down-regulation of MAT
might be correlated with reversible inactivation of MTAP, as has
been shown in the present study, to compensate the impaired
SAM synthesis leading to maintenance of cellular MTA. Cellular
antioxidant defences might reactivate MAT [42] and MTAP
returning methionine catabolism and salvage pathways to their
normal steady-state. However, the maintenance of the diseased
condition results in a persistent impairment of liver MAT [43]
and MTAP [19] gene expression through epigenetic mechanisms.
In light of these observations it might by hypothesized that
impairment of SAM synthesis might be compensated, at least
partially, by inactivation of MTAP leading to maintenance of
MTA levels that may be critical for cellular stability. The idea
of a co-ordinated regulation of MTA metabolism by the redox
state of the cell might be further reinforced by results indicating
the inactivation of SAM decarboxylase by reactive species [44].
Interestingly, it has been reported that the hepatic levels of
putrescine are increased in murine liver upon treatment with
LPS resulting from up-regulation of ornithine decarboxylase.
However, the increment of putrescine did not promote a parallel
increase in spermidine and spermine (Figure 6) [45]. Our results
might explain these observations since MTA, which accumulates
in the liver of LPS-treated mice as a result of MTAP inactivation,
inhibits spermine and spermidine synthases [1,6].
Protein oxidation is a common regulatory mechanism of meta-
bolic and signalling pathways [46]. Native MTAP is a homo-
trimer with active sites composed entirely of residues of the
same subunit with the exception of His137 and Leu279 that are
provided by the neighbouring monomer [13]. The loss of MTAP
activity upon exposure to H2O2 is a reversible process that results
from the specific oxidation of cysteine residues 136 and 223
as was demonstrated by using the purified enzyme as well as
cellular systems whose MTA consumption capacity was severely
impaired after an oxidative challenge. These two cysteine residues
are conserved in mammalian MTAPs and in the Drosophila
melanogaster orthologue but are not present in other MTAP
sequences, explaining the lack of cysteine-mediated redox
regulation reported in different archaea species [11]. No structural
or functional evidence support a direct participation of cysteine
residues in MTA binding or in the catalytic mechanism of MTAP,
consistent with our finding that the activity of the enzyme remains
as in the WT protein when cysteine residues were replaced by
serine. However, specific oxidation of Cys136 and Cys223 resulted in
a reduced Vmax while the Km of the enzyme remained unchanged,
suggesting that the binding of MTA to the active site of MTAP is
not modified in the oxidized form. Interestingly, Cys223 is located
on a flexible loop over the active-site cleft of MTAP connecting
β-strand 11 with α-helix 5 and is close to Asp220 and Asp222
which participate in the catalytic process and Cys136 is adjacent to
His137 that integrates the MTA-binding pocket of the neighbouring
subunit [13]. Moreover, non-conservative substitution of Cys223 by
tyrosine resulted in an inactive MTAP mutant [47]. Therefore it is
tempting to speculate that the oxidation of Cys136 and Cys223 might
alter the microenvironment of these catalytic residues modifying
their chemical reactivity and consequently the activity of the
enzyme.
Oxidation of the two cysteine residues is required to promote
MTAP inactivation as indicated by the loss of sensitivity of
C136S and C233S mutants to inactivation by H2O2. The idea of a
disulfide interaction between these residues arises as a probable
explanation to the co-ordinated effect of the two oxidation events
on MTAP inactivation. However, the distances separating the
corresponding sulphur atoms of Cys136 and Cys233 from adjacent
subunits are 15.77 Å (1 Å = 0.1 nm) and 35.54 Å in the same
MTAP monomer [13], too far away to allow prediction of their
interaction without assuming conformational rearrangements that
to our knowledge have not yet been demonstrated. Consistently,
the only disulfide bond clearly identified upon oxidation with
H2O2 involved Cys145 and Cys211 as expected from the 3.63 Å
separating their thiol groups. Additionally DTNB titration data
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indicate that six cysteine residues from the MTAP monomer
become oxidized upon incubation with H2O2 and therefore two
cysteine residues supplementary to Cys136, Cys145, Cys211 and
Cys223 may undergo oxidation.
Incubation of MTAP with H2O2 led to oxidation of Cys136 and
Cys223 to reversible sulfenic acid. Longer exposures of MTAP to
H2O2 to those reported in the present study resulted in oxidized
forms that displayed hydrodynamic volumes larger than those
expected for the monomer when analysed by size-exclusion
chromatography under denaturing conditions (Supplementary
Figure 2). This observation may suggest a reversible inter-
subunit interaction that should involve Cys136 and Cys223 since
the effect was reversed by reducing agents, and mutants lacking
these residues failed to accumulate the putatively cross-linked
intermediate. Since no disulfide interactions additional to Cys145-
S-S-Cys211 were detected, our observations may be explained
alternatively assuming the stabilization of Cys136 and/or Cys223
sulfenic derivatives through reaction with residues located in
the adjacent monomer leading to the formation of reversible
intermediates such as sulfenyl amides [48,49]. This notion might
find further support on the time-dependent reduction of sulfenic
content per protein subunit observed after oxidation periods
longer than 30 min, suggesting their stabilization to derivatives
that were recycled back to reduced thiols with reducing agents
(Supplementary Figure 2). Detailed structural studies are required
to demonstrate these hypotheses and to fully elucidate the ROS-
induced oxidation intermediates of MTAP.
In summary, the results of the present study support the loss
of MTAP activity in the liver of LPS-challenged mice as well as
in HepG2 cells exposed to t-butyl hydroperoxide. MTAP activity
is regulated by mechanisms involving the specific and reversible
oxidation of cysteine residues Cys136 and Cys233 to sulfenic acid
that may be further stabilized to a sulfenyl amide intermediate.
Additional oxidation events result in disulfide bonding of Cys145
and Cys211 thiols, although this modification has no impact on the
enzymatic activity of MTAP. In the liver this regulatory mechan-
ism might provide means to maintain intracellular MTA levels
under stress conditions such as those imposed by inflammatory
reactions ensuring hepatocyte viability.
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